Filtros : "Pharmaceutics" "PLANEJAMENTO DE FÁRMACOS" Removido: "EERP" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidades: IFSC, FFCLRP

    Subjects: CRISTALOGRAFIA, PLANEJAMENTO DE FÁRMACOS, NEOPLASIAS (TRATAMENTO), CITOTOXINAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FAILACHE, Natalia Alvarez et al. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents. Pharmaceutics, v. 15, n. 5, p. 1345-1-1345-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051345. Acesso em: 09 nov. 2024.
    • APA

      Failache, N. A., Costa, A. R., Collazo, V., Ellena, J., Costa Filho, A. J. da, Batista, A. A., & Facchin, G. (2023). Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents. Pharmaceutics, 15( 5), 1345-1-1345-18 + supplementary materials. doi:10.3390/pharmaceutics15051345
    • NLM

      Failache NA, Costa AR, Collazo V, Ellena J, Costa Filho AJ da, Batista AA, Facchin G. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents [Internet]. Pharmaceutics. 2023 ; 15( 5): 1345-1-1345-18 + supplementary materials.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/pharmaceutics15051345
    • Vancouver

      Failache NA, Costa AR, Collazo V, Ellena J, Costa Filho AJ da, Batista AA, Facchin G. Development of copper complexes with diimines and dipicolinate as anticancer cytotoxic agents [Internet]. Pharmaceutics. 2023 ; 15( 5): 1345-1-1345-18 + supplementary materials.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/pharmaceutics15051345
  • Source: Pharmaceutics. Unidade: FCF

    Assunto: PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEON, Rosmery Merma et al. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, v. 15, p. 1-20 art. 1735, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061735. Acesso em: 09 nov. 2024.
    • APA

      Leon, R. M., Issa, M. G., Duque, M. D., Daniel, J. S. P., & Ferraz, H. G. (2023). Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, 15, 1-20 art. 1735. doi:10.3390/pharmaceutics15061735
    • NLM

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
    • Vancouver

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/pharmaceutics15061735

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024